82 related articles for article (PubMed ID: 1338991)
1. [ELISA of serum isoferritin and its clinical application].
Cai G; Zeng W; Lu S; Chen P; Zhao Y; Cai Y
Hua Xi Yi Ke Da Xue Xue Bao; 1992 Sep; 23(4):367-9. PubMed ID: 1338991
[TBL] [Abstract][Full Text] [Related]
2. [Observation of the serum acidic isoferritin levels in patients with hepatocellular carcinoma].
Zou L; Hao D; Cai G; Wei L
Hua Xi Yi Ke Da Xue Xue Bao; 1997 Dec; 28(4):424-7. PubMed ID: 10683960
[TBL] [Abstract][Full Text] [Related]
3. [Detection of isoferritin level in breast cancer tissue and serum].
Cai G; Zeng W; Chen P; Lü S; Zhao Y; Yang H
Hua Xi Yi Ke Da Xue Xue Bao; 1994 Mar; 25(1):15-7. PubMed ID: 8070763
[TBL] [Abstract][Full Text] [Related]
4. [Detection of serum isoferritin level in 195 patients with cancer].
Cai G; Wei L; Lü S; Hao D; Li Z
Hua Xi Yi Ke Da Xue Xue Bao; 1995 Dec; 26(4):395-7. PubMed ID: 8732059
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunoassay of human cardiac acidic isoferritin: a new index for hepatic cancer.
Jin J; Zhang M; Wang B; Xiao H; Sun J
Chin Med J (Engl); 1998 Feb; 111(2):150-3. PubMed ID: 10374377
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.
Tangkijvanich P; Chanmee T; Komtong S; Mahachai V; Wisedopas N; Pothacharoen P; Kongtawelert P
J Gastroenterol Hepatol; 2010 Jan; 25(1):129-37. PubMed ID: 19793164
[TBL] [Abstract][Full Text] [Related]
7. Serum CD166: a novel hepatocellular carcinoma tumor marker.
Ma L; Lin J; Qiao Y; Weng W; Liu W; Wang J; Sun F
Clin Chim Acta; 2015 Feb; 441():156-62. PubMed ID: 25562819
[TBL] [Abstract][Full Text] [Related]
8. Significance of combined tests of serum golgi glycoprotein 73 and other biomarkers in diagnosis of small primary hepatocellular carcinoma.
Zhao Y; Wang M; Cui C; Zhang L; Liao F; Li H; Wu X
Cancer Biomark; 2015; 15(5):677-83. PubMed ID: 26406957
[TBL] [Abstract][Full Text] [Related]
9. Validity of plasma macrophage migration inhibitory factor for diagnosis and prognosis of hepatocellular carcinoma.
Zhao YM; Wang L; Dai Z; Wang DD; Hei ZY; Zhang N; Fu XT; Wang XL; Zhang SC; Qin LX; Tang ZY; Zhou J; Fan J
Int J Cancer; 2011 Nov; 129(10):2463-72. PubMed ID: 21213214
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody CM-H-9 detects circulating placental isoferritin in the serum of patients with visceral metastases of breast cancer.
Rosen HR; Flex D; Stierer M; Moroz C
Cancer Lett; 1991 Aug; 59(2):145-51. PubMed ID: 1884372
[TBL] [Abstract][Full Text] [Related]
11. Serum 90K/MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alpha-fetoprotein.
Iacovazzi PA; Trisolini A; Barletta D; Elba S; Manghisi OG; Correale M
Clin Chem Lab Med; 2001 Oct; 39(10):961-5. PubMed ID: 11758611
[TBL] [Abstract][Full Text] [Related]
12. High preoperative levels of serum glypican-3 containing N-terminal subunit are associated with poor prognosis in patients with hepatocellular carcinoma after partial hepatectomy.
Haruyama Y; Yorita K; Yamaguchi T; Kitajima S; Amano J; Ohtomo T; Ohno A; Kondo K; Kataoka H
Int J Cancer; 2015 Oct; 137(7):1643-51. PubMed ID: 25784484
[TBL] [Abstract][Full Text] [Related]
13. Serological AFP/Golgi protein 73 could be a new diagnostic parameter of hepatic diseases.
Tian L; Wang Y; Xu D; Gui J; Jia X; Tong H; Wen X; Dong Z; Tian Y
Int J Cancer; 2011 Oct; 129(8):1923-31. PubMed ID: 21140449
[TBL] [Abstract][Full Text] [Related]
14. NMR and LC/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis.
Liu Y; Hong Z; Tan G; Dong X; Yang G; Zhao L; Chen X; Zhu Z; Lou Z; Qian B; Zhang G; Chai Y
Int J Cancer; 2014 Aug; 135(3):658-68. PubMed ID: 24382646
[TBL] [Abstract][Full Text] [Related]
15. Serum placental isoferritin and breast cancer prognosis.
Stierer M; Rosen HR; Moroz C
Breast Cancer Res Treat; 1990 Nov; 17(1):63. PubMed ID: 2095930
[No Abstract] [Full Text] [Related]
16. The Haptoglobin β chain as a supportive biomarker for human lung cancers.
Kang SM; Sung HJ; Ahn JM; Park JY; Lee SY; Park CS; Cho JY
Mol Biosyst; 2011 Apr; 7(4):1167-75. PubMed ID: 21253648
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of clinical significance of isoferritin by development of new monoclonal antibodies specific for acidic isoferritin.
You SY; Zhang CY; Yi XP; Huang W
Hybridoma; 2001 Aug; 20(4):243-8. PubMed ID: 11604110
[TBL] [Abstract][Full Text] [Related]
18. Serum ferritin in hepatocellular carcinoma.
Zhou XD; Stahlhut MW; Hann HL; London WT
Hepatogastroenterology; 1988 Feb; 35(1):1-4. PubMed ID: 2452122
[TBL] [Abstract][Full Text] [Related]
19. The clinical value of serum ferritin in hepatocellular carcinoma.
Simonetti RG; Craxi A; Dardanonì G; Lanzarone F; Barbaria F; Cottone M; Pagliaro L
Hepatogastroenterology; 1985 Dec; 32(6):276-8. PubMed ID: 2419233
[TBL] [Abstract][Full Text] [Related]
20. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.
Soga K; Watanabe T; Aikawa K; Toshima M; Shibasaki K; Aoyagi Y
Hepatogastroenterology; 1998; 45(23):1737-41. PubMed ID: 9840138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
